Notice: This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrends LOGC vs. HLF, MYTE, SFIX, CURV, HZO, EXTO, SPTN, BBW, THCH, and BHShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include Herbalife (HLF), MYT Netherlands Parent B.V. (MYTE), Stitch Fix (SFIX), Torrid (CURV), MarineMax (HZO), Almacenes Éxito (EXTO), SpartanNash (SPTN), Build-A-Bear Workshop (BBW), TH International (THCH), and Biglari (BH). These companies are all part of the "retail/wholesale" sector. LogicBio Therapeutics vs. Herbalife MYT Netherlands Parent B.V. Stitch Fix Torrid MarineMax Almacenes Éxito SpartanNash Build-A-Bear Workshop TH International Biglari LogicBio Therapeutics (NASDAQ:LOGC) and Herbalife (NYSE:HLF) are both small-cap retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk. Does the media refer more to LOGC or HLF? In the previous week, Herbalife had 5 more articles in the media than LogicBio Therapeutics. MarketBeat recorded 5 mentions for Herbalife and 0 mentions for LogicBio Therapeutics. Herbalife's average media sentiment score of 0.42 beat LogicBio Therapeutics' score of 0.00 indicating that Herbalife is being referred to more favorably in the news media. Company Overall Sentiment LogicBio Therapeutics Neutral Herbalife Neutral Do institutionals and insiders hold more shares of LOGC or HLF? 46.1% of LogicBio Therapeutics shares are owned by institutional investors. 0.4% of LogicBio Therapeutics shares are owned by insiders. Comparatively, 0.9% of Herbalife shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is LOGC or HLF more profitable? Herbalife has a net margin of 1.73% compared to LogicBio Therapeutics' net margin of -141.03%. Herbalife's return on equity of -18.66% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LogicBio Therapeutics-141.03% -81.98% -52.13% Herbalife 1.73%-18.66%7.12% Does the MarketBeat Community prefer LOGC or HLF? Herbalife received 624 more outperform votes than LogicBio Therapeutics when rated by MarketBeat users. Likewise, 67.26% of users gave Herbalife an outperform vote while only 64.08% of users gave LogicBio Therapeutics an outperform vote. CompanyUnderperformOutperformLogicBio TherapeuticsOutperform Votes9164.08% Underperform Votes5135.92% HerbalifeOutperform Votes71567.26% Underperform Votes34832.74% Which has higher earnings and valuation, LOGC or HLF? Herbalife has higher revenue and earnings than LogicBio Therapeutics. LogicBio Therapeutics is trading at a lower price-to-earnings ratio than Herbalife, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicBio Therapeutics$287M0.62-$317M-$5.79-1.16Herbalife$5.06B0.13$142.20M$0.857.76 Do analysts recommend LOGC or HLF? Herbalife has a consensus price target of $9.90, indicating a potential upside of 50.09%. Given Herbalife's stronger consensus rating and higher probable upside, analysts clearly believe Herbalife is more favorable than LogicBio Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicBio Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Herbalife 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Which has more risk and volatility, LOGC or HLF? LogicBio Therapeutics has a beta of 2.04, meaning that its share price is 104% more volatile than the S&P 500. Comparatively, Herbalife has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. SummaryHerbalife beats LogicBio Therapeutics on 14 of the 17 factors compared between the two stocks. Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$180.58M$1.24M$25.23B$9.13BDividend YieldN/AN/A167.13%4.00%P/E RatioN/AN/A109.1217.29Price / Sales0.620.083.62137.12Price / CashN/AN/A21.1132.88Price / Book0.75N/A6.774.69Net Income-$317M-$16.07M$678.42M$224.57M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics0.5637 of 5 stars$6.74-1.9%N/AN/A$180.58M$287M0.0062HLFHerbalife4.6458 of 5 stars$6.49-1.5%$9.90+52.5%-46.8%$654.14M$5.00B7.649,200MYTEMYT Netherlands Parent B.V.1.1149 of 5 stars$7.59+3.4%$4.88-35.8%+222.7%$647.17M$855.09M-16.871,817News CoverageGap UpSFIXStitch Fix1.8035 of 5 stars$4.99+5.5%$3.96-20.6%+61.0%$632.92M$1.29B-6.017,920Gap DownCURVTorrid1.9923 of 5 stars$5.74+1.2%$5.20-9.4%+13.6%$601.31M$1.12B38.272,060Analyst ForecastNews CoverageHZOMarineMax4.4004 of 5 stars$26.36-1.1%$41.83+58.7%-15.8%$598.16M$2.43B15.983,410Upcoming EarningsGap UpEXTOAlmacenes ÉxitoN/A$3.64+0.3%N/A-47.6%$590.53M$21.01T0.0043,134Positive NewsGap DownSPTNSpartanNash4.1709 of 5 stars$17.49+0.3%$20.00+14.4%-18.0%$590.38M$9.53B13.1516,500Analyst DowngradeNews CoverageBBWBuild-A-Bear Workshop3.9921 of 5 stars$41.44-1.1%$52.50+26.7%+82.2%$556.95M$495.24M11.024,550THCHTH International0.2484 of 5 stars$3.12-6.5%N/A-93.1%$517.66M$1.45B-6.124,621High Trading VolumeBHBiglari3.6251 of 5 stars$218.51+0.2%N/A+46.1%$497.33M$361.66M1.242,466 Related Companies and Tools Related Companies Herbalife Alternatives MYT Netherlands Parent B.V. Alternatives Stitch Fix Alternatives Torrid Alternatives MarineMax Alternatives Almacenes Éxito Alternatives SpartanNash Alternatives Build-A-Bear Workshop Alternatives TH International Alternatives Biglari Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LOGC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LOGC Stock Alerts